AR019981A1 - Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida. - Google Patents
Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida.Info
- Publication number
- AR019981A1 AR019981A1 ARP990103817A ARP990103817A AR019981A1 AR 019981 A1 AR019981 A1 AR 019981A1 AR P990103817 A ARP990103817 A AR P990103817A AR P990103817 A ARP990103817 A AR P990103817A AR 019981 A1 AR019981 A1 AR 019981A1
- Authority
- AR
- Argentina
- Prior art keywords
- solid
- pharmaceutical composition
- prepare
- procedure
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composicion farmacéutica de liberacion sostenida que comprende una mezcla comprimida de un ingrediente farmacologicamente activo y un portador deliberacion sostenida que comprende goma xantano donde la goma xantano es capaz de disolverse en aguaa una concentracion de una parte den peso de goma xantanopor 100 partes en peso de agua para formar una solucion que tiene una transmision (600 nm) de más del 50% solida, y un procedimiento para preparar una forma dedosificacion solida.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9816723.2A GB9816723D0 (en) | 1998-08-01 | 1998-08-01 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR019981A1 true AR019981A1 (es) | 2002-03-27 |
Family
ID=10836508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990103817A AR019981A1 (es) | 1998-08-01 | 1999-07-30 | Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1100471B1 (es) |
| JP (1) | JP2002522376A (es) |
| CN (1) | CN1160060C (es) |
| AR (1) | AR019981A1 (es) |
| AT (1) | ATE249815T1 (es) |
| AU (1) | AU744483B2 (es) |
| CA (1) | CA2339190C (es) |
| DE (1) | DE69911427T2 (es) |
| DK (1) | DK1100471T3 (es) |
| ES (1) | ES2207274T3 (es) |
| GB (1) | GB9816723D0 (es) |
| MX (1) | MXPA01000992A (es) |
| NZ (1) | NZ509593A (es) |
| PT (1) | PT1100471E (es) |
| WO (1) | WO2000007569A1 (es) |
| ZA (1) | ZA200100828B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030130297A1 (en) | 2001-07-06 | 2003-07-10 | Endo Pharmaceuticals, Inc. | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| US20030091635A1 (en) * | 2001-09-26 | 2003-05-15 | Baichwal Anand R. | Opioid formulations having reduced potential for abuse |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4135979A (en) * | 1976-08-24 | 1979-01-23 | Merck & Co., Inc. | Treatment of xanthan gum to improve clarity |
| GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
| US4915948A (en) * | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
| CA2017249C (en) * | 1989-05-24 | 2000-07-25 | Theresa M. Ortega | Rheology controlled fabric printing composition and method |
-
1998
- 1998-08-01 GB GBGB9816723.2A patent/GB9816723D0/en not_active Ceased
-
1999
- 1999-07-28 DE DE69911427T patent/DE69911427T2/de not_active Expired - Fee Related
- 1999-07-28 AU AU55087/99A patent/AU744483B2/en not_active Ceased
- 1999-07-28 CA CA002339190A patent/CA2339190C/en not_active Expired - Fee Related
- 1999-07-28 PT PT99941487T patent/PT1100471E/pt unknown
- 1999-07-28 AT AT99941487T patent/ATE249815T1/de not_active IP Right Cessation
- 1999-07-28 NZ NZ509593A patent/NZ509593A/xx unknown
- 1999-07-28 MX MXPA01000992A patent/MXPA01000992A/es unknown
- 1999-07-28 CN CNB998113735A patent/CN1160060C/zh not_active Expired - Fee Related
- 1999-07-28 EP EP99941487A patent/EP1100471B1/en not_active Expired - Lifetime
- 1999-07-28 DK DK99941487T patent/DK1100471T3/da active
- 1999-07-28 JP JP2000563255A patent/JP2002522376A/ja active Pending
- 1999-07-28 WO PCT/EP1999/005499 patent/WO2000007569A1/en active IP Right Grant
- 1999-07-28 ES ES99941487T patent/ES2207274T3/es not_active Expired - Lifetime
- 1999-07-30 AR ARP990103817A patent/AR019981A1/es unknown
-
2001
- 2001-01-30 ZA ZA200100828A patent/ZA200100828B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002522376A (ja) | 2002-07-23 |
| MXPA01000992A (es) | 2002-06-04 |
| CA2339190C (en) | 2008-11-18 |
| DK1100471T3 (da) | 2004-01-12 |
| AU5508799A (en) | 2000-02-28 |
| NZ509593A (en) | 2002-12-20 |
| ATE249815T1 (de) | 2003-10-15 |
| CN1354653A (zh) | 2002-06-19 |
| AU744483B2 (en) | 2002-02-28 |
| EP1100471A1 (en) | 2001-05-23 |
| CN1160060C (zh) | 2004-08-04 |
| DE69911427T2 (de) | 2004-07-01 |
| PT1100471E (pt) | 2003-12-31 |
| CA2339190A1 (en) | 2000-02-17 |
| WO2000007569A1 (en) | 2000-02-17 |
| GB9816723D0 (en) | 1998-09-30 |
| EP1100471B1 (en) | 2003-09-17 |
| DE69911427D1 (de) | 2003-10-23 |
| ES2207274T3 (es) | 2004-05-16 |
| ZA200100828B (en) | 2001-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR080436A2 (es) | Preparacion solida de desintegracion rapida, uso de una hidroxipropilcelulosa poco sustituida en dicha preparcion y metodo para mejorar la desintegrabilidad oral de la misma | |
| AR059324A2 (es) | Una forma solida de dosificacion oral | |
| AR036700A1 (es) | Forma de dosificacion oral solida de simeticona | |
| AR042937A2 (es) | Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento | |
| BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
| CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
| CO4340618A1 (es) | Composicion farmaceutica para liberacion controlada | |
| AR040722A1 (es) | Formulaciones y formas de dosificacion para la administracion controlada de topiramato | |
| PE20060075A1 (es) | Composiciones farmaceuticas de alisciren | |
| ES2177346T3 (es) | Formulaciones de ranolazina de liberacion lenta. | |
| CO5190672A1 (es) | Composicion para la dosificacion oral, de disolucion instantanea | |
| BR0109091A (pt) | Formulações de ranolazina de liberação sustentada | |
| HUP0000141A2 (hu) | Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására | |
| BRPI0410116A (pt) | tablete de cuidado oral | |
| ECSP034826A (es) | Método para fabricar una composición farmacéutica de dosis baja | |
| AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
| ATE367165T1 (de) | Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen | |
| BR0214497A (pt) | Composição farmacêutica que compreende um agonista do receptor 5ht1 | |
| ES2182526T3 (es) | Metodo para mejorar las propiedades ingenieriles del suelo. | |
| CL2004001843A1 (es) | Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax | |
| AR019981A1 (es) | Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida. | |
| PE20011113A1 (es) | Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina | |
| AR036755A1 (es) | Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel | |
| CO5640085A2 (es) | Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato | |
| PE20050359A1 (es) | Composiciones topicas que comprenden terbinafina e hidrocortisona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |